Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Recurrence
×
enasidenib
×
Clear all
Filters
3
NCT04092179
2024-01-24
ENAVEN-AML
University Health Network, Toronto
Phase 1/2
Terminated
27 enrolled